Temasek’s 65 Equity Makes Europe Foray With Swiss Pharma Merger

Asset manager 65 Equity Partners is backing Swiss pharmaceutical ingredient maker Healthcare Advanced Synthesis SA’s acquisition of Cerbios-Pharma SA, marking its first deal in Europe.Read More